SAMC
PGNX

Shinko Asset Management Company’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Shinko Asset Management Company’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$682K Sell
107,663
-32,528
-23% -$197K ﹤0.01% 228
2016
Q2 		$592K Hold
140,191
– – ﹤0.01% 230
2016
Q1 		$611K Hold
140,191
– – ﹤0.01% 204
2015
Q4 		$859K Buy
140,191
+56,941
+68% +$373K 0.01% 201
2015
Q3 		$476K Buy
+83,250
New +$639K ﹤0.01% 219

Other funds holding PGNX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Shinko Asset Management Company's PGNX Position: Q3 2016 in Review

Shinko Asset Management Company reduced its Progenics Pharmaceuticals Inc (PGNX) stake by 23% in Q3 2016, selling an estimated $197K and leaving 107,663 shares worth $682K. The position accounts for ﹤0.01% of the portfolio, ranked #228.

Shinko Asset Management Company first reported a position in PGNX in Q3 2015 and has held it in 5 quarters since. The position peaked at $859K in Q4 2015. 115 funds tracked by Wall St. Rank hold PGNX as of Q3 2016.

  • Shinko Asset Management Company held 107,663 shares of Progenics Pharmaceuticals Inc worth $682K as of Q3 2016.
  • Shinko Asset Management Company sold 32,528 Progenics Pharmaceuticals Inc shares in Q3 2016, an estimated $197K.
  • Progenics Pharmaceuticals Inc made up ﹤0.01% of Shinko Asset Management Company's portfolio in Q3 2016, its #228 holding.
  • Shinko Asset Management Company first reported a position in Progenics Pharmaceuticals Inc in Q3 2015 and has held it in 5 quarters since.
  • Shinko Asset Management Company's Progenics Pharmaceuticals Inc position peaked at $859K in Q4 2015.
  • 115 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q3 2016.

Based on Shinko Asset Management Company's 13F filing for Q3 2016, filed 24 Oct 2016.